PathAI
AI-enabled digital pathology platform with image management and algorithm access.
Last updated: June 5, 2026
Back to directoryDigital pathology AI applications for cancer pathology, including Paige Prostate.
Pathology teams evaluating AI support for prostate biopsy review and digital pathology workflows.
Compare within workflow: Digital pathology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Paige as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify the exact Paige product, scanner, tissue type, and intended use, especially for prostate workflows that have FDA-authorized claims. |
|---|---|
| Privacy | Review whole-slide image storage, cloud processing, LIS links, access controls, retention, and any secondary-use terms before diagnostic deployment. |
| Evidence | Validate performance in the local lab across scanner, stain, tissue preparation, case mix, pathologist workflow, and cancer-prevalence differences. |
| Workflow | Best used as pathologist-supervised digital pathology support where suspicious regions, exceptions, and final diagnostic responsibility remain reviewable. |
Paige describes AI applications for cancer pathology and a prostate suite for detection and diagnosis support.
Not for: Use beyond authorized indications, scanners, or pathologist-supervised review.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.